Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
[google_news title=”” keyword=”Shortages of life-saving drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Shortages of life-saving drugs
- Medicine shortage in England now 'beyond critical' with seven drugs unavailableon May 8, 2024 at 11:10 pm
An NHS medicine shortages in England ‘beyond critical’, pharmacists have warned. A survey has revealed challenges faced by pharmacists and risk of harm to patients as key drugs from the NHS are ...
- New bill aims to establish provider incentive program to combat drug shortageson May 7, 2024 at 10:30 am
A new draft bill from the Senate Finance Committee aims to establish a new provider incentive program to address drug shortages. | A new draft bill from the Senate Finance Committee aims to establish ...
- Bipartisan Senate panel proposes new drug shortages legislationon May 3, 2024 at 9:47 am
“Prescription drug shortages are fueling high prices and limiting access to life-saving treatments and cures,” ranking member Mike Crapo (R-ID) said, adding that the bill would “take meaningful ...
- Coach's death spotlights pharma's profit wins in chemo drug shortageon May 3, 2024 at 9:07 am
As reported by NBC News in May 2023, US Food and Drug Administration Commissioner Dr. Robert Califf said there's not enough profit in producing chemo drugs because many are generic and do not have a ...
- Beloved high school football coach who couldn’t get chemotherapy drug due to national shortage dead at 60on April 30, 2024 at 11:09 pm
A beloved Wisconsin high school football coach died from his stage 4 cancer after the life-saving chemotherapy drug he needed for his treatment became unavailable due to a nationwide shortage. Jeff ...
- Alarm over shortage of life-saving insulin as GP warns ‘type 1 diabetics fall ill and die in days without it’on April 30, 2024 at 7:32 am
PEOPLE with type 1 diabetes fear their lives could be at risk as the UK faces shortages of “vital” insulin. Insulin, which helps the body regulate blood sugar levels, is one of ...
- Pakistan faces shortage of life-saving drugson April 25, 2024 at 3:46 am
Pakistan is again facing shortage of essential medicines, including life-saving drugs, causing stress for patients and citizens, ARY News reported on ...
- Drug shortages at highest since 2014: Chemo drugs, Wegovy, ADHD medications affectedon April 18, 2024 at 6:46 pm
Since 2001, the groups have tracked shortages using voluntary reports from practitioners and patients that are confirmed by drug makers. Both basic and life-saving drugs are in short supply ...
- Shortages of life saving medicines has become ‘new normal’ for UK after Brexiton April 18, 2024 at 12:18 am
Analysing freedom of information requests and public data on drug shortages, researchers found there is now more than double the number of notifications from drug companies warning of impending ...
- Urgent warning over shortages of life-saving drugs: Damning report reveals patients are at risk because of Britain's 'broken' medicine supply chain... so are stocks of YOUR ...on April 17, 2024 at 5:00 pm
Sick Britons are facing alarming drug shortages and being made to wait ... a real and present danger to those patients who rely on life-saving medicines for their wellbeing,' he added.
via Bing News